Fong Fiona Long Yan, El-Nezami Hani, Mykkänen Otto, Kirjavainen Pirkka V
School of Biological Sciences, The University of Hong Kong, Pokfulam, Hong Kong, SAR China.
Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Front Nutr. 2022 Apr 12;9:773298. doi: 10.3389/fnut.2022.773298. eCollection 2022.
Probiotic bacteria have potential use as immunomodulators but comparative data on their immunological effects are very limited. The aim of this study was to characterize the effect of oral administration of probiotic strains, alone or as mixtures, on systemic and organ-specific immune responses. For this purpose, healthy C57BL/6 mice were perorally administered probiotics for 3 weeks. A total of five common probiotic strains, species GG (LGG) and LC705, 99 (Bb99), JS (PJS), and Nissle 1917 (EcN), and two of their mixtures, were tested. Livers, spleens, and blood were collected for investigation. A number of five treatments increased the abundance of the natural killer (NK) cells. Bb99 had the most prominent effect on hepatic NK cells (20.0 ± 1.8%). LGG (liver: 5.8 ± 1.0%; spleen: 1.6 ± 0.4%), Bb99 (liver: 13.9 ± 4.3%; spleen: 10.3 ± 3.7%), and EcN (liver: 8.5 ± 3.2%; spleen: 1.0 ± 0.2%) increased the percentage of both the hepatic and splenic T-helper 17 cells. Moreover, LGG (85.5 ± 3.0%) and EcN (89.6 ± 1.2%) increased the percentage of splenic regulatory T-cells. The tested mixtures of the probiotics had different immunological effects from their individual components on cell-mediated responses and cytokine production. In conclusion, our results confirm that the immunomodulatory potential of the probiotics is strain- and organ/tissue-specific, and the effects of probiotic mixtures cannot be predicted based on their single constituents.
益生菌有作为免疫调节剂的潜在用途,但关于其免疫效应的比较数据非常有限。本研究的目的是描述口服益生菌菌株单独或混合使用对全身和器官特异性免疫反应的影响。为此,对健康的C57BL/6小鼠口服益生菌3周。共测试了五种常见的益生菌菌株,即鼠李糖乳杆菌GG(LGG)、LC705、嗜热栖热放线菌99(Bb99)、约氏乳杆菌JS(PJS)和嗜酸乳杆菌Nissle 1917(EcN),以及它们的两种混合物。收集肝脏、脾脏和血液进行研究。五种处理中有几种增加了自然杀伤(NK)细胞的丰度。Bb99对肝脏NK细胞的影响最为显著(20.0±1.8%)。LGG(肝脏:5.8±1.0%;脾脏:1.6±0.4%)、Bb99(肝脏:13.9±4.3%;脾脏:10.3±3.7%)和EcN(肝脏:8.5±3.2%;脾脏:1.0±0.2%)增加了肝脏和脾脏辅助性T细胞17的百分比。此外,LGG(85.5±3.0%)和EcN(89.6±1.2%)增加了脾脏调节性T细胞的百分比。所测试的益生菌混合物在细胞介导反应和细胞因子产生方面与其单个成分具有不同的免疫效应。总之,我们的结果证实益生菌的免疫调节潜力具有菌株和器官/组织特异性,并且不能根据其单一成分预测益生菌混合物的效果。